Cigna lifts annual profit view on lower medical costs, pharmacy benefit strength
By Bhanvi Satija (Reuters) -Cigna Group raised its annual profit forecast on Thursday, helped by lower-than-expected medical costs and strength in its pharmacy benefit management unit. The health insurer's second forecast raise this year is in sharp co...
15h ago
IQVIA trims full-year revenue forecast on stronger dollar
(Reuters) - Contract research firm IQVIA Holdings lowered its annual revenue forecast on Thursday due to a stronger dollar and reported a quarter-over-quarter fall in a closely-watched metric, sending shares down nearly 4%. The company expects 2024...
16h ago
Digital health startup Transcarent valued at $2.2 billion after latest funding round
(Reuters) - Digital health startup Transcarent notched a valuation of $2.2 billion after its latest fund raise, led by General Catalyst and 7wireVentures, amid signs of a rebound in the funding market. The company said on Thursday it had raised $12...
16h ago
Novo Nordisk: Wegovy, Ozempic prices in US fell in Q1
LONDON (Reuters) - Novo Nordisk has seen the price of its hugely popular weight-loss drug Wegovy and diabetes drug Ozempic fall in the United States as volumes and competition have increased, a senior executive said on Thursday. Wegovy prices in th...
19h ago
Cardinal Health lifts 2024 profit view on demand for costly specialty drugs
(Reuters) - Cardinal Health raised its annual profit forecast on Thursday, betting on strength in its pharmaceutical unit selling costly specialty drugs used to treat complex conditions such as cancer. Drug distributors, including rival Cencora, ha...
19h ago
Baxter raises annual profit forecast on strong demand for medical devices
(Reuters) - Medical device maker Baxter International raised its annual profit forecast and beat quarterly estimates on Thursday, banking on strong demand for its infusion pumps and dialysis products. Investor expectations around the performance of...
19h ago
Zimmer Biomet beats Q1 profit estimates on robust demand for knee, hip devices
(Reuters) - Medtech firm Zimmer Biomet Holdings beat Wall Street estimates for first-quarter profit on Thursday, on the back of robust demand for its devices that are used in knee and hip reconstruction procedures. Zimmer's results extend a strong ...
20h ago
Zoetis beats profit estimates on strong demand for pet products
(Reuters) - Animal healthcare company Zoetis surpassed analysts' expectations for first-quarter profit on Thursday, helped by strong demand for its medicines and vaccines for pets. Zoetis deals with vaccines, medicines and diagnostic solutions for ...
20h ago
Teleflex beats quarterly profit estimates on healthy demand for medical devices
(Reuters) - Teleflex reported a better-than-expected first-quarter profit on Thursday, on the back of strong demand for its medical devices. The Wayne, Pennsylvania-based company also raised the lower end of its 2024 adjusted profit forecast to $13...
21h ago
Novartis to buy radiology specialist Mariana Oncology for $1 billion
(Reuters) - Novartis has entered an agreement to acquire US radiopharmaceutical company Mariana Oncology for $1 billion, the Swiss drug manufacturer said on Thursday. The deal also includes $750 million of potential further payments upon achieving ...
21h ago